Genwang Pei, Rongfeng Lin, Guangqi Li, Yinyan Lai
Journal: Frontiers in endocrinology 2026;17():1868955
PMID: 42395188
Phosphaturic mesenchymal tumours (PMTs), which are common causes of tumour-induced osteomalacia (TIO), are exceptionally uncommon in the sinonasal tract and skull base. PMTs are characterized by their nonspecific location, small size, and indolent growth. When they occur in the sinonasal region and skull base, they often lack typical sinonasal symptoms, which poses significant diagnostic challenges and contributes to high rates of missed and misdiagnosis. A retrospective analysis was conducted on 5 patients with pathologically confirmed sinonasal/skull base PMTs treated at our institution from December 2015 to March 2025. The study cohort comprised three male and two female patients aged 28 to 67 years. The sites of involvement were the left sinonasal cavity (n = 3), right sinonasal cavity (n = 1), and sinonasal skull base (n = 1), with all patients undergoing surgical resection of the lesions. Our findings indicate that the increased incidence of missed and misdiagnoses primarily arises from tumour obscurity, atypical clinical manifestations, and insufficient clinical recognition of the condition. Persistent hypophosphataemia provides vital diagnostic information. PET demonstrating somatostatin receptor positivity and immunohistochemistry revealing SSTR2+/SATB2+ expression are key auxiliary diagnostic tools. Monitoring postoperative serum phosphorus levels can aid in the effective evaluation of cure and recurrence.
Copyright © 2026 Pei, Lin, Li and Lai.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.